Early help for people with arthritis

Our funding helped to establish The Barts Early Arthritis Referral Centre, which sees patients within two weeks of referral and has increased remission rates by 40%.

We’re dedicated to

Responding to unmet medical needs.

Traditional rheumatoid arthritis treatment methods apply drugs on a trial and error basis, but this proves ineffective for up to 40% of patients, leaving them in continuing pain and discomfort.

The difference we’re making

  • Creating a new facility which sees arthritis patients within two weeks of GP referral
  • Tailoring treatments - developing new tests to help identify which drug is best suited to the individual patient
  • Improving remission rates for this debilitating disease – 24% in remission compared to the 17% national average
  • Saving the NHS money by funding research that ensures drug treatments are more likely to be effective 
  • Improving the research science in this area - the Centre has gone on to have 96 papers published in medical journals of national and international importance
See how you can make a difference too

What the hospital staff are saying

“We wanted to help the thousands of people suffering because they weren't getting the right treatment early enough. Without Barts Charity's funding, all we have achieved would have been impossible.”

– Costantino Pitzalis, Head of Centre for Experimental Medicine & Rheumatology

Giving 100%

We were one of the first funders of the Barts Early Arthritis Referral Centre, enabling its creation. The first clinic was at Mile End Hospital and now there is a second clinic at Newham University Hospital.

The Centre sees around 2,500 patients a year.

The Centre is continuing its research into better treatments for arthritis sufferers, currently running 12 medical trials.

It is also developing a mobile app to improve how patients monitor and record their disease and their response to treatment.

100% of your gift goes to extraordinary projects like this.

Donate now

More like this

PlasmaJet

New “PlasmaJet” equipment is helping staff treat patients with advanced ovarian cancer. It works like a surgical “blowtorch”, enabling staff to remove tissue from tricky locations.

PlasmaJet